CHAPTER 5 Paediatric Renal Replacement Therapy

Slides:



Advertisements
Similar presentations
ESRD Registry Committee, Korean Society of Nephrology*
Advertisements

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20 th MDTR Report 2012,
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
UK Renal Registry 13th Annual Report
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
First-year death rates by modality figure 8
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Summary of the 2013 ERA-EDTA Registry Annual Report
UK Renal Registry 16th Annual Report
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study  S.-Y. Li, T.-J. Chen, K.-W. Chung,
UK Renal Registry 19th Annual Report
Table 4.1: Cumulative distribution of QoL-Index score in relation to dialysis modality, all dialysis patients
CHAPTER 11: Haemodialysis Practices
CHAPTER 3 Death and Survival on Dialysis
Volume 2: End-Stage Renal Disease
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Fig 6.1 Frequency of ischaemic heart disease in incident patients
CHAPTER 10 Hepatitis on Dialysis
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
Volume 67, Issue 4, Pages (April 2005)
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 14th Annual Report
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Worldwide incidence of ESRD figure 12.1, per million population
UK Renal Registry 16th Annual Report
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Stock and Flow of Peritoneal Dialysis Patients Australia
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

CHAPTER 5 Paediatric Renal Replacement Therapy

Table 5.1: Stock and flow of Paediatric Renal Replacement Therapy (RRT), 2007-2016

Figure 5.1(a): Incidence cases of RRT by modality in children under 20 years old, 2007-2016

Figure 5.1(b): Prevalence cases of RRT by modality in children under 20 years old, 2007-2016

Table 5.2: Paediatric dialysis and transplant rates per million age related population, 2007-2016

Figure 5.2: Incidence and prevalence rate per million age related population, 2007-2016

Table 5.3(a): Dialysis treatment rate by state, per million state age related population, 2007-2016

Table 5.3(b): New dialysis patients by state, 2007-2016

Table 5.4: Number of new dialysis and transplant patients by gender, 2007-2016

Figure 5.4: Number of new dialysis and transplant patients by gender, 2007-2016

Table 5.5: New RRT rate, per million age related population by age group, 2007-2016

Figure 5.5: New RRT rate by age group, 2007-2016

Table 5.6: New dialysis by treatment modality, 2007-2016

Figure 5.6: New dialysis by treatment modality, 2007-2016

Table 5.7: New dialysis by sector, 2007-2016

Figure 5.7: New dialysis by sector, 2007-2016

Table 5.8: Primary renal disease by sex among new dialysis patients, 2007-2016

Table 5.9: Types of renal transplantation, 2007-2016

Table 5.10(a): Patient survival by dialysis modality analysis (not censored with change of modality), 2007-2016

Figure 5.10(a): Patient survival by dialysis modality analysis (not censored with change of modality), 2007-2016

Table 5.10(b): Patient survival by dialysis modality analysis (censored with change of modality), 2007-2016

Figure 5.10(b): Patient survival by dialysis modality analysis (censored with change of modality), 2007-2016

Table 5.11: Causes of death in dialysis patients, 2007-2016

Table 5.12: Dialysis technique survival by modality, 2007-2016

Figure 5.12: Dialysis technique survival by modality, 2007-2016

Table 5.13: Reasons for drop-out from PD program, 2007-2016

Table 5.14: Transplant graft survival, 2007-2016

Figure 5.14: Transplant graft survival, 2007-2016

Table 5.15: Causes of graft loss, 2007-2016

Table 5.16: Vascular access on haemodialysis, 2007-2016

Table 5.17(a): Distribution of prescribed Kt/V, HD patients 2012-2016

Table 5.17(b): Distribution of delivered Kt/V, HD patients 2012-2016

Table 5.17(c): Distribution of URR, HD patients 2012-2016

Table 5.18: Treatment for anaemia, HD patients 2007-2016

Table 5.19: Distribution of transferrin saturation on Erythropoietin, HD patients 2007-2016

Table 5.20: Distribution of transferrin saturation on Erythropoietin, PD patients 2007-2016

Table 5.21: Distribution of ESA dose (u/wk), 2007-2016

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.